| Literature DB >> 34156523 |
Felix J Woitek1, Stephan Haussig1, Johannes Mierke1, Axel Linke1, Norman Mangner2.
Abstract
Remote proctoring by advanced digital technologies may help to overcome pandemic, geographic, and resource-related constraints for mentoring and educating interventional cardiology skills. We present a case series of patients undergoing high-risk percutaneous coronary intervention (HR-PCI) with mechanical circulatory support (MCS) guided by remote proctoring to gain insights into a streaming technology platform with regard to video/audio quality, visibility of all structural and imaging details, and delay in transmission. According to our experience, remote proctoring appears to be a reliable, quick, and resource-conserving way to disseminate, educate and improve MCS-supported HR-PCI with implications far beyond the COVID-19 pandemic.Entities:
Keywords: High-risk PCI; Impella; Mechanical circulatory support; Remote proctoring
Mesh:
Year: 2021 PMID: 34156523 PMCID: PMC8217783 DOI: 10.1007/s00392-021-01890-3
Source DB: PubMed Journal: Clin Res Cardiol ISSN: 1861-0684 Impact factor: 5.460
Fig. 1TEGUS remote proctoring system showing the stand-alone freely moveable tripod with focus on the high definition camera and the Bluetooth headset (A). The stand-alone freely moveable tripod is best positioned at the foot of the floating cath lab table (red box in the lower part of the B) providing the audiovisual connection to the proctor in the password secured and encrypted data transfer TEGUS platform (upper part of B)
Fig. 2Screenshots from the TEGUS online platform of the operating field (A), angiography (B), intravascular ultrasound (C), the Impella® controller (D), and hemodynamics (E)
Baseline characteristics, procedural details and in-hospital outcomes
| Patient # 1 | Patient # 2 | Patient # 3 | Patient # 4 | Patient # 5 | Patient # 6 | |
|---|---|---|---|---|---|---|
| Patient characteristics | ||||||
| Age, years | 86 | 89 | 86 | 67 | 81 | 86 |
| Sex | male | male | male | male | male | male |
| Body mass index, (kg/m2) | 26.8 | 22.9 | 26.1 | 32.5 | 34.4 | 32.7 |
| Clinical presentation | Unstable angina pectoris | NSTEMI | Cardiac decompensation | Cardiac decompensation | NSTEMI | NSTEMI |
| Comorbidities | Arterial hypertension, status post 2-chamber-pacemaker due to sick sinus syndrome, previous stroke | Arterial hypertension, PAD, carotid disease, chronic renal disease (GFR 39 ml/min) | Arterial hypertension, PAD, Diabetes mellitus, COPD, chronic renal failure (GFR 61 ml/min) | Arterial hypertension, carotid disease, complex PAD with recent femoral-popliteal bypass left and lower leg amputation right, hip replacement, consequently poor mobility | Arterial hypertension, diabetes mellitus | Arterial hypertension, chronic renal failure (GFR 60 ml/min) |
| Previous myocardial infarction | No | No | No | No | No | No |
| Previous PCI | No | Yes (RCA 1 week before HR-PCI) | No | No | No | No |
| Previous cardiac surgery | No | No | No | No | No | No |
| LV-EF, % | 40 | 25 | 17 | 23 | 65 | 35 |
| Valvular heart disease | No | AS II°, MR II° | No | AS II°, TR II° | AS I°, MS II°, MR II° | No |
| Procedural characteristics | ||||||
| Impella® | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| Access site | Right common femoral artery | Left common femoral artery | Right common femoral artery | Right common femoral artery | Right common femoral artery | Left common femoral artery |
| Single access strategy | Yes | Yes | Yes | Yes | Yes | Yes |
| Coronary artery disease | 2-vessel disease | 3-vessel disease | 3-vessel disease | 3-vessel disease | 3-vessel diseases | 3-vessel disease |
| Dominance | left | right | left | right | left | right |
| Left main > 50% | Yes (Medina 1-1-0) | Yes (Medina 1-1-1) | Yes (Medina 1-0-0) | Yes (Medina 1-1-1) | Yes (Medina 1-1-1) | Yes (Medina 1-1-1) |
| Proximal LAD > 75% | Yes | Yes | No | Yes | Yes | Yes |
| CTO | No | No | No | Yes (RCA) | Yes (RCA) | No |
| Target vessel(s) | Left main, LAD | Left main, LAD, Cx | Left main | Left main, LAD, Cx | Left main, LAD, Cx | Left main, LAD, Cx |
| Rotablation | No | No | No | Yes (left main/Cx) | Yes (left main/LAD + left main/Cx) | Yes (left main/LAD) |
| Cutting balloon | Yes | No | Yes | No | Yes | No |
| Bifurcation technique | Provisional Stenting left main | Mini-Crush left main | No | DK-Crush left main | DK-Crush left main | DK-Crush left main |
| Intravascular imaging use | No | No | No | No | IVUS | IVUS |
| Access site closure | MANTA 14F | MANTA 14F | MANTA 14F | MANTA 14F | MANTA 14F | MANTA 14F |
| Procedure duration, min | 90 | 108 | 65 | 126 | 157 | 114 |
| Contrast dye, cc | 150 | 200 | 170 | 100 | 170 | 240 |
| Fluoroscopy, min | 14.2 | 11.2 | 9.1 | 29 | 40.3 | 25.4 |
| In-hospital outcomes | ||||||
| Death | No | No | No | No | No | No |
| Acute renal failure | No | No | No | No | No | No |
| Stroke | No | No | No | No | No | No |
| Major vascular complication | No | No | No | No | No | No |
| Major bleeding | No | No | No | No | No | No |
| Length of hospital stay after PCI, days | 1 | 1 | 1 | 7 | 1 | 3 |
NSTEMI non-ST segment elevation myocardial infarction, PAD peripheral artery disease, COPD chronic obstructive pulmonary disease, RCA right coronary artery, (HR)-PCI (high-risk) percutaneous coronary intervention, AS aortic stenosis, MR mitral regurgitation, TR tricuspid regurgitation, MS mitral stenosis, LAD left anterior descending coronary artery, Cx circumflex coronary artery, CTO chronic total occlusion, IVUS intravascular ultrasound